GALECTIN THERAPEUTICS INC Annual Interest Expense in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Galectin Therapeutics Inc quarterly/annual Interest Expense history and growth rate from 2017 to 2023.
  • Galectin Therapeutics Inc Interest Expense for the quarter ending March 31, 2024 was $1.05M, a 129% increase year-over-year.
  • Galectin Therapeutics Inc Interest Expense for the twelve months ending March 31, 2024 was $3.38M, a 167% increase year-over-year.
  • Galectin Therapeutics Inc annual Interest Expense for 2023 was $2.79M, a 170% increase from 2022.
  • Galectin Therapeutics Inc annual Interest Expense for 2022 was $1.03M, a 111% increase from 2021.
  • Galectin Therapeutics Inc annual Interest Expense for 2021 was $489K, a 462% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $2.79M +$1.76M +170% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-29
2022 $1.03M +$544K +111% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-29
2021 $489K +$402K +462% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 $87K $0 0% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 $87K -$249K -74.1% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-31
2018 $336K +$324K +2700% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-16
2017 $12K Jan 1, 2017 Dec 31, 2017 10-K 2019-03-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.